Lawsuits Over Losartan, Irbesartan Consolidated With Valsartan Recall Claims
A panel of federal judges has ordered all losartan and irbesartan recall lawsuits folded into consolidated valsartan litigation.
Tag Archives: Irbesartan
-
-
Valsartan, Losartan Recall Problems Leads To FDA Warning Letter For Torrent Pharmaceuticals
The FDA has issued a warning letter to Torrent Pharmaceuticals regarding problems at a losartan manufacturing plant in India as part of its investigation into contaminated hypertension drugs.
-
FDA Taking Too Long To Assess Cancer Problems with Valsartan, Other Blood Pressure Drugs: Report
A new analysis warns that the FDA has only screened a quarter of all valsartan and similar high blood pressure medications for cancer-causing impurities.
-
Motion Seeks To Add Irbesartan and Losartan Lawsuits to Pending Valsartan Litigation
A status conference this week will discuss whether losartan and irbesartan lawsuits should be added to a valsartan recall lawsuit MDL, as all three drugs saw massive recalls over cancer-causing…
-
Cancer Risk from Valsartan, Losartan, Other Recalled Blood Pressure Drugs Still Being Investigated by FDA
The FDA is expanding its hunt for cancer-causing impurities in drugs beyond hypertension medications like valsartan.
-
Valsartan Recalls May Have Been Caused By Indian Solvent Recovery Firm, At Least In Part: FDA
A solvent company in India received a warning letter from the FDA, indicating it may have played a role in massive generic valsartan recalls issued over cancer-causing impurities.
-
Valsartan Recalls Resulted in Increase In Reports of Cancer Among Former Users: Report
A new study questions the increase in cancer-related reports linked to valsartan following a series of recalls that began last summer, saying they may have been the result of alarm…
-
Core Discovery Underway in Lawsuits Over Valsartan Contamination
A new order sets core discovery rules for valsartan lawsuits filed over claims that recalled generic drugs were tainted with cancer-causing agents.
-
FDA Releases List of 40 Hypertension Drugs That Do Not Contain Potentially Cancer-Causing Impurities
The FDA is providing a list of 40 blood pressure medications it says are free of cancer-causing impurities, but warns that shortages will increase beyond valsartan.
-
More Irbesartan Tablet Recalls Issued Over NDEA Contamination
Eight lots of irbesartan and irbesartan HCTZ are being recalled due to the presence of cancer-causing impurities.
